Theravance Biopharma (TBPH) Non-cash Items (2015 - 2025)

Theravance Biopharma (TBPH) has 10 years of Non-cash Items data on file, last reported at $1.8 million in Q4 2025.

• Non-cash Items for Q4 2025 came in at $1.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (changed N/A YoY), and the FY2025 annual result was $1.8 million, changed N/A from the prior year.
• Non-cash Items improved to $1.8 million in Q4 2025 per TBPH's latest filing, from $859000.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $1.8 million in Q4 2025 and troughed at $775000.0 in Q4 2022.
• A 4-year average of $1.1 million and a median of $964500.0 in 2021 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items dropped 27.57% in 2022, then climbed 10.84% in 2023.
• A 4-year view of Non-cash Items shows it stood at $1.1 million in 2021, then retreated by 27.57% to $775000.0 in 2022, then grew by 10.84% to $859000.0 in 2023, then jumped by 111.52% to $1.8 million in 2025.
• Business Quant data shows TBPH's Non-cash Items at $1.8 million in Q4 2025, $859000.0 in Q4 2023, and $775000.0 in Q4 2022.